Xianhao Shao

Dr. Xianhao Shao


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2023 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
YZYuhang Zhao
Yuhang Zhao
XSXianhao Shao
Xianhao Shao
CCCai Chen
Cai Chen
JSJunlin Song
Junlin Song
CTChongxuan Tian
Chongxuan Tian
WLWei Li
Wei Li
Deep learning for cell instance segmentation is a significant research direction in biomedical image analysis. The traditional supervised learning methods rely on pixel-wise annotation of object images to train the models, which is often accompanied by time-consuming and labor-intensive. Various modified segmentation methods, based on weakly supervised or semi-supervised learning, have been proposed to recognize cell regions by only using rough annotations of cell positions. However, it is still hard to achieve the fully unsupervised in most approaches that the utilization of few annotations for training is still inevitable. In this paper, we propose an end-to-end unsupervised model that can segment individual cell regions on hematoxylin and eosin (H&E) stained slides without any annotation. Compared with weakly or semi-supervised methods, the input of our model is in the form of raw data without any identifiers and there is no need to generate pseudo-labelling during training. We demonstrated that the performance of our model is satisfactory and also has a great generalization ability on various validation sets compared with supervised models. The ablation experiment shows that our backbone has superior performance in capturing object edge and context information than pure CNN or transformer under our unsupervised method.

20 April 2023 in Orthopaedic Surgery
Verified
Journal Article
Open access
XSXianhao Shao
Xianhao Shao
HDHao Ding
Hao Ding
JLJianmin Li
Jianmin Li
ZLZhaorui Lv
Zhaorui Lv
QYQiang Yang
Qiang Yang
ZLZhenfeng Li
Zhenfeng Li
Objective: Using a fibula autograft (FA) to reconstruct defects after en bloc resection of giant cell tumor of bone (GCTB) in the distal radius is classic but has high complication rates. We describe a novel reconstruction method employing the cooperative application of LARS® and a 3D‐printed prosthesis (L‐P) and investigate whether it improves postoperative outcomes.Methods: From April 2015 to August 2022, 14 patients who underwent the cooperative L‐P reconstruction method after en bloc resection of distal radial GCTBs and 31 patients who received FA reconstruction were enrolled as two retrospective cohorts in this comparative study. The properties of the implants and critical surgical techniques were elaborated in the L‐P group. Preoperative function, intraoperative data, and postoperative clinical, functional, and radiographic outcomes of all patients were recorded and compared between the two groups. The grip strength and range of wrist motion, including extension, flexion, radial deviation, and ulnar deviation, were measured. The Mayo modified wrist and Musculoskeletal Tumor Society scores were chosen to assess wrist function and surgical functional outcomes, respectively. Kaplan–Meier curves were generated to analyze the significant differences in complication rates and implant survival between the two groups.Results: In both groups, all 45 patients underwent the operation without complication with similar average osteotomy lengths and bleeding volumes, while a shorter operative duration was achieved in the L‐P group (201.43 ± 22.87 min vs. 230.16 ± 51.44 min, P = 0.015). At a mean follow‐up of 40.42 ± 18.43 months (range, 14–72 months), both reconstruction methods effectively ameliorated postoperative function. Patients who received L‐P showed higher postoperative modified Mayo wrist scores (81.43 ± 5.49 vs. 71.13 ± 16.10, P = 0.003), Musculoskeletal Tumor Society scores (27.64 ± 1.34 vs. 25.06 ± 2.95, P = 0.004), and grip strength on the normal side (68.71% ± 8.00% vs. 57.81% ± 12.31%, P = 0.005) than the FA group. Better wrist extension (63.21° ± 8.99° vs. 45.32° ± 14.53°, P < 0.001) and flexion (45.36° ± 7.90° vs. 30.48° ± 12.07°, P < 0.001) were also observed in the L‐P group. The complication rate was significantly higher in the FA group (29/31, 93.55%) than in the L‐P group (1/14 7.14%, P < 0.001). The L‐P group showed higher implant survival than the FA group, but the difference was not statistically significant.Conclusion: The cooperative application of LARS® and 3D‐printed prostheses is an effective modality for reconstructing musculoskeletal defects after en bloc resection of distal radial GCTBs, which can improve functional outcomes, diminish complication rates, and promote wrist joint stability and motion.

19 December 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
FSFeifei Sun
Feifei Sun
YQYing Qu
Ying Qu
SMShuyu Mei
Shuyu Mei
LZLin Zhang
Lin Zhang
XSXianhao Shao
Xianhao Shao
BHBo Han
Bo Han
Although androgen receptor (AR)-targeted therapies, such as enzalutamide, initially improve outcomes of prostate cancer (PCa) patients, resistance inevitably develops, partly driven by prostate cancer stem-like cells (PCSCs). However, the molecular mechanisms linking the maintenance of PCSCs to enzalutamide resistance (ENZR) remain incompletely elucidated. Here, we implicate Ca²⁺/calmodulin-dependent protein kinase 1D (CAMK1D) in PCSC-mediated ENZR. CAMK1D was consistently upregulated in PCa with ENZR and contributed to ENZR by enhancing mitophagy in PCa cells both in vitro and in vivo. Mechanistically, CAMK1D promotes the expansion of PCSCs by enhancing mitophagy through activation of the AMP-activated protein kinase (AMPK)/PINK1 signaling pathway, thereby facilitating cellular adaptation. We revealed that CAMK1D interacts with and phosphorylates AMPK at Thr172, which in turn activates PINK1 to modulate mitophagy, ultimately supporting the expansion of PCSCs under enzalutamide treatment. In a mouse orthotopic PCa model, targeting the CAMK1D/AMPK pathway with the siCAM/HLNP nanoformulation suppresses tumor growth by depleting the PCSCs population, achieving a synergistic effect with enzalutamide therapy. Our findings identify CAMK1D as a key regulator of ENZR that maintains stemness by orchestrating mitophagy, thereby establishing mitophagy as an important nexus between CAMK1D-mediated ENZR and AMPK-driven PCSC enrichment. Therapeutically, we developed a CAMK1D-targeted approach that potently reverses ENZR and improves treatment responses.

24 February 2022 in Orthopaedic Surgery
Verified
Journal Article
Open access
PDF file
XSXianhao Shao
Xianhao Shao
JLJian‐Min Li
Jian‐Min Li
AZAi‐Lin Zhang
Ai‐Lin Zhang
YYYuan Yao
Yuan Yao
FSFei‐Fei Sun
Fei‐Fei Sun
KCKun Cheng
Kun Cheng
Objective: To explore whether there exist undiscovered transphyseal vasculature‐canal compound structures in immature femurs and tibias, and reveal their potential oncological impact.Methods: This investigation was divided into a morphological study and a clinical study. In the morphological part, a new‐identified anatomic structure was investigated by using radiographical, anatomical, and histological methodologies. Twenty‐eight 1‐mm‐slice thickness magnetic resonance images of pediatric knees were generated and 10 pediatric knees were dissected to verify the existence and universality, observe the radiographic and anatomic characteristics, and determined the located region of this structure. Hematoxylin–eosin staining, immunofluorescence, and angiography procedures were performed to illustrate its histological feature, molecular identification, and vascular origination, respectively. In the clinical part, 38 pediatric osteosarcoma patients were enrolled from January 2014 to December 2020. A descriptive clinical study including 13 typical participants was conducted to investigate the oncological significance of this new‐identified structure. Meanwhile, the discrepancy in transphyseal osteosarcoma extension between different physeal regions was evaluated in a cross‐sectional study.Results: In the morphological study, we discovered a new‐found vasculature‐canal compound structure, intercondylar transphyseal complex (ITC), which originated from the middle genicular vessels, traversed the whole epiphysis, and breached the intact open physis in the immature proximal tibia or distal femur. The components of ITC included the juxta‐articular, epiphyseal, and transphyseal segments of vessels, the canals that traverse the entire epiphysis and physis and enclosed the vessels, vascular foramina on articular facet and foramina‐covered synovium. Depending on the location, ITCs can be divided into three types: femoral ITC, anterior tibial ITC, and posterior tibial ITC. Clinically, the ITC may facilitate intercondylar transphyseal sarcomatous dissemination without damaging the adjacent physeal cartilage. Compared to bilateral condylar physes, more osteosarcomas transgressed the open growth plates through intercondylar regions in which ITC was located (P = 0.022).Conclusion: As the “gap” on intact open physis, ITC, which is a new‐identified compound structure in intercondylar regions of immature femur or tibia, may promote intercondylar transphyseal tumor extension. Moreover, the identification and characterization of ITC subvert some traditional comprehensions about physis and may provide novel perspectives for pediatric osteosarcomas.

7 February 2026 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
XLXinyue Li
Xinyue Li
MDMengmeng Dou
Mengmeng Dou
MYMengqi Yan
Mengqi Yan
YCYuezhi Cui
Yuezhi Cui
FSFeifei Sun
Feifei Sun
XSXianhao Shao
Xianhao Shao

11 August 2025 in Orthopaedic Surgery
Verified
Journal Article
Open access
MDMengmeng Dou
Mengmeng Dou
JYJinfeng Yang
Jinfeng Yang
JLJiaoran Li
Jiaoran Li
JLJianmin Li
Jianmin Li
ZLZhenzhong Li
Zhenzhong Li
KCKun Cheng
Kun Cheng
Objective: The objective of this study is to achieve distinct visualization of juxta‐articular intraosseous microvessels, a novel nanoimaging methodology in which superparamagnetic iron oxide nanoparticles and meglumine diatrizoate (MD) are used cooperatively was implemented.Methods: A newly created composite of MD and Fe3O4 nanoparticles (MD‐Fe3O4 NPs) was prepared as a contrast agent to achieve efficacious imaging of the juxta‐articular intraosseous vasculature‐canal complex (JIVCC). Scanning electron microscopy (SEM) and energy dispersive spectrum (EDS) were employed to observe the structural characteristics and binding stability of the MD‐Fe3O4 NPs. In 20 rabbits that received an injection of MD‐Fe3O4 NPs, 1‐mm‐thick computed tomography (CT) scanning was performed for radiographic assessment. Hematoxylin–eosin‐ and potassium ferrocyanide‐stained sections from 10 sacrificed rabbits were used to observe the histological characteristics of JIVCC with MD‐Fe3O4 NPs, and the remaining 10 rabbits were utilized for a systemic safety evaluation. After a healthy volunteer received an MD‐Fe3O4 NP injection, we also performed CT scanning and related safety evaluations.Results: When the MD nanoparticles and amino‐Fe3O4 nanoparticles were mixed together, they aggregated into a stable compound structure according to microscopic observations and SEM–EDS verification. In 20 rabbits receiving MD‐Fe3O4 injections, 1‐mm slice CT imaging demonstrated significantly enhanced visualization of the JIVCCs in magnet‐placed knees compared to contralateral limbs (tibial JIVCC: p < 0.001; femoral JIVCC: p < 0.001), confirming MD‐Fe3O4 NPs as the efficacious magnetic contrast enhancer. The histological characteristics of MD‐Fe3O4 NPs in JIVCC were revealed. The levels of serum iron before and 4 and 72 h after MD‐Fe3O4 NP injection were 23.9 ± 2.13 μmol/L, 26.2 ± 2.30 μmol/L, and 24.9 ± 2.33 μmol/L, respectively, indicating that there was no significant difference in safety (p = 0.092). After a volunteer received MD‐Fe3O4 NPs via intravenous administration, the JIVCC was clearly visualized, laboratory tests of serum iron levels were normal, and no injection‐related complications occurred.Conclusions: A novel compound nanoparticle, which achieved satisfactory overall outcomes, was implemented as an appropriate alternative for the discernible visualization of juxta‐articular intraosseous microvessels. The nanotechnology utilized in this study may augment the clinical imaging methodology for the osseous vascular system.